Clinical Oncology: Head and Neck Cancers

SCIENTIFIC COORDINATOR: Lisa Licitra, IT
 
The online course on head and neck cancers is addressed to an International audience of clinical oncologists interested in advancing their knowledge and skills on the clinical management of these tumors in a multidisciplinary context.
 
Taking into account that “networking” is the keyword  to improve quality of care of rare cancers, the course is developed in the framework of EURACAN, the European Reference Network on rare adult solid cancers, with the aim of reinforcing  the collaboration among oncologists of different countries who are already part of the network or willing to be part of it in the near future.
 
The course will also be part of the “Career development educational pathway on Rare Adult Solid Cancers” (more information about the full educational programme on rare cancers will be published on the ESO website in the coming months).

FORMAT
The course is made up of a series of pre-recorded lectures (available online from 10 May 2021).
 
LEARNING OBJECTIVES 
- To provide an overview of current multidisciplinary state-of-the-art treatment of head and neck cancers
- To establish connections for future distance clinical mentoring/tutoring/networking
 
PARTICIPANT'S PROFILE
• Medical degree
• Current involvement in clinical activities in oncology
• Fluency in English
 
OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.
 
CME ACCREDITATION CERTIFICATES
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certficate that will be issued by email. 
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 10 CME credits have been granted to this event.
The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
CME credits will be available until 10 May 2023.
 
 

ESCO CREDITS
The course enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Course earns participants 10 ESCO credits.
Visit www.esco.org for information on how to join ESCO.
 
REGISTRATION
Registration for the course is required but free (you can find the registration link on the right).
Registration will be confirmed by e-mail.
 
ORGANISING SECRETARIAT
Marina Fregonese
email: mfregonese@eso.net
phone: +39 02 23902106

SOCIAL MEDIA
Use the hashtag #ESOexperience and follow us on Facebook, Twitter and Instagram: @esoncology
 

Introduction

10/05/2021

The natural history and biology
Expert: Lisa Licitra, IT

Epidemiology
Expert: Gemma Gatta, IT

Imaging
Expert: Frank Pameijer, NL

Pathology
Expert: Keith Hunter, UK

Oral cavity (OC) and Oropharyngeal cancer (OPC)

10/05/2021

Oral cavity
Expert: Christian Simon, CH

HPV negative OPC
Expert: Sandra Nuyts, BE

HPV positive OPC
Expert: Ricard Mesìa, ES

Transoral surgery in OPC
Expert: Cesare Piazza, IT

Cancers of larynx and hypopharynx

10/05/2021

Radiation for larynx and hypopharynx
Expert: Vincent Gregoire, FR

Endoscopic surgery for larynx and hypopharynx
Expert: Cesare Piazza, IT

Principles of organ preservation
Expert: Lisa Licitra, IT

Medical therapy of recurrent and metastatic disease
Expert: Jean-Pascal Machiels, BE

Salvage surgery
Expert: C. René Leemans, NL

Re-irradiation
Expert: Vincent Gregoire, FR

Supportive care
Expert: Salvatore Alfieri, IT

Nutrition in the curative setting
Expert: Salvatore Alfieri, IT

Rehabilitation
Expert: Antonio Schindler, IT

Rare cancers of the head and neck

10/05/2021

Nasopharyngeal cancer
Expert: Pierre Blanchard, FR

Radiation therapy in nasal, paranasal and salivary gland cancers
Expert: Ester Orlandi, IT

Nasal cavity and paranasal sinus cancers
Expert: Paolo Bossi, IT

Salivary gland cancer
Expert: Robert Metcalf, UK

Salvatore Alfieri

Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy

Pierre Blanchard

Institut Gustave Roussy, Villejuif, France

Paolo Bossi

Humanitas University, Milan, Italy

Gemma Gatta

National Cancer Institute - IRCCS Foundation, Milan, Italy

Vincent Gregoire

Centre Leon Berard, Lyon, France

Keith Hunter

School of Clinical Dentistry, Sheffield, United Kingdom

C. René Leemans

VU University Medical Center, Amsterdam, The Netherlands

Lisa Licitra

Medical Oncologist, National Cancer Institute - IRCCS Foundation, Milan, Italy

Jean-Pascal Machiels

Institut Roi Albert II Cancer Center, Brussels, Belgium

Ricard Mesìa

Catalan Institute of Oncology, Badalona, Spain

Robert Metcalf

The Christie NHS Foundation Trust, Manchester, United Kingdom

Sandra Nuyts

University Hospitals Leuven, Leuven, Belgium

Ester Orlandi

Radiation oncologist, Centro Nazionale Adroterapia Oncologica, Pavia, Italy

Frank Pameijer

University Medical Center, Utrecht, The Netherlands

Cesare Piazza

Università degli Studi di Brescia, Brescia, Italy

Antonio Schindler

Luigi Sacco Hospital, Milan, Italy

Christian Simon

Université de Lausanne, CHUV, Lausanne, Switzerland


logo

In partnership with

In collaboration with